On Thursday, October 26, 2017, President Donald Trump declared the opioid crisis a national health emergency.
From 2000 to 2015, more than half a million people died of drug overdoses across the country and most of those deaths involved opioids, according to the Centers for Disease Control and Prevention (CDC). The CDC estimates that 64,000 people died from drug overdoses in 2016 alone.…
Continue Reading Trump Declares Opioid Epidemic a Public Health Emergency
Attorney General Christopher S. Porrino recently announced that New Jersey has filed a lawsuit against Insys Therapeutics, Inc. charging that the company engaged in a “greed-driven campaign of consumer fraud and submission of false claims to health insurers” to increase the market share for its opioid-fentanyl drug, Subsys.
The complaint asserts that Subsys has Food and Drug Administration (FDA) approval only for the treatment of opioid-tolerant cancer pain, yet Insys unlawfully directed its sales people to “push Subsys for prescription to a broader patient population – patients suffering any type of chronic pain – and at higher doses.” The state’s lawsuit alleges that corporate decision-makers sought to expand the limited market for Subsys by aggressively pushing “off label” uses of the drug.…
Continue Reading New Jersey Files Lawsuit Against Opioid Manufacturer
